Data as of Dec 12
| +0.09 / +0.75%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 16.50, with a high estimate of 20.00 and a low estimate of 15.00. The median estimate represents a +36.14% increase from the last price of 12.12.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.